CuspAI, a UK-based AI startup, has secured $400 million in funding, significantly boosting its valuation to $2.6 billion. This financing round, which has garnered support from notable investors including Jeff Bezos, represents a substantial increase in the company's worth in just two years since its inception.
Startup FundingGenerative AIAI+1
Startup FundingGenerative AIAICuspAI
Jeff Bezos Invests in CuspAI, Elevating Valuation to $2.6 Billion with $400 Million Funding
Financial Times Tech· Thursday, June 18, 2026
More Articles From This Day
Generative AINLP+2
Generative AINLPHealthcareAI Chemist
Near-Autonomous AI Chemist Enhances Key Drug-Making Reaction in Medicinal Chemistry
OpenAI, in collaboration with Molecule.one, has demonstrated how a near-autonomous AI chemist powered by GPT-5.4 has successfully improved a crucial reaction in drug manufacturing. This advancement represents a significant step forward in medicinal chemistry research, showcasing the potential of AI technologies to enhance complex chemical processes.